Development of Escitalopram Genomic Device by Using Candidate Gene Approach and Genome-Wide Scanning.
Active, no longer recruiting
Phase of Trial: Phase III
Latest Information Update: 01 Feb 2016
At a glance
- Drugs Escitalopram (Primary)
- Indications Depressive disorders
- Focus Therapeutic Use
- 30 Dec 2015 According to ClinicalTrials.gov record, the treatment table has been amended to include 2 arms.
- 30 Dec 2015 Planned End Date changed from 1 Dec 2015 to 1 Dec 2016, according to ClinicalTrials.gov record.
- 04 Jun 2015 Planned End Date changed from 1 Jan 2013 to 1 Dec 2015 as per ClinicalTrials.gov record.